Related Experiment Video

Updated: Jul 16, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest

Luciana E Giono1, James J Manfredi

  • 1Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA. james.manfredi@mssm.edu

Molecular and Cellular Biology
|March 21, 2007
PubMed

Insights

Mdm2 is crucial for p53-mediated cell cycle arrest. Upregulating p53 without Mdm2 allows target gene activation but fails to inhibit Cdk2, preventing growth arrest.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • p53 protein is a critical tumor suppressor.
  • Cellular stress induces post-translational modifications of p53.
  • These modifications regulate p53's stability, DNA binding, and transcriptional activity.

Purpose of the Study:

  • To investigate the role of Mdm2 in p53-dependent cell cycle arrest.
  • To compare the effects of doxorubicin and Mdm2 siRNA on p53 activity.
  • To determine the mechanism by which Mdm2 influences p53's function.

Main Methods:

  • Small interfering RNA (siRNA) to downregulate Mdm2.
  • Doxorubicin treatment to induce cellular stress.
  • Analysis of p53 post-translational modifications (phosphorylation, acetylation).
  • Assessment of p53 binding to the p21 promoter.
  • Evaluation of p53 target gene expression and cell cycle progression.
  • Investigation of p21 interaction with Cyclin-dependent kinase 2 (Cdk2).

Main Results:

  • Mdm2 siRNA increased p53 levels but reduced specific post-translational modifications.
  • Both doxorubicin and Mdm2 siRNA increased p53 binding to the p21 promoter.
  • p53 upregulated by Mdm2 siRNA activated target genes but did not induce cell cycle arrest.
  • p21, though interacting with Cdk2, failed to inhibit its activity in the absence of Mdm2.

Conclusions:

  • Mdm2 plays a vital role in p53-dependent cell cycle arrest.
  • Mdm2 is required for p21 to fully inhibit Cdk2 activity.
  • Downregulation of Mdm2 impairs the tumor-suppressive function of p53.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...